SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
73 hedge funds and large institutions have $213M invested in scPharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 27 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% less capital invested
Capital invested by funds: $291M → $213M (-$77.7M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
Holders
73
Holding in Top 10
2
Calls
$1.3M
Puts
$36K
Top Buyers
| 1 | +$13.5M | |
| 2 | +$2.76M | |
| 3 | +$2.69M | |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.11M |
| 5 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
+$890K |
Top Sellers
| 1 | -$5.35M | |
| 2 | -$2.71M | |
| 3 | -$948K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$935K |
| 5 |
JFG
Jefferies Financial Group
New York
|
-$608K |